{
  "Cancer Histology Subtype (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1174, 
        1180
      ]
    }
  ], 
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1181, 
        1190
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2142, 
        2165
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1050, 
        1077
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1257, 
        1282
      ]
    }
  ], 
  "Laterality (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1094, 
        1098
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        579, 
        608
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        968, 
        994
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1165, 
        1173
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1079, 
        1092
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1099, 
        1105
      ]
    }
  ], 
  "Relative Location (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1107, 
        1117
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PATHLAB_LIS|HOSPITAL 4^9999^MOH|PIMS|CCO|20160504000301|3D954690D0B41615E21B31B25BACEC86E49E72F8|ORU^R01|1605040003415421|P|2.5|||\nPID|1||9999999^^^^CMR^HOSPITAL 4&9999&MOH~9999999^^^^MRN^HOSPITAL 4&9999&MOH~9999999999&VB&ON^^^^JHN||XXXXX^XXXXXX^^^^||99999999|F|^^^^^||9999  XXXXX XXXXXX XX^^XXXXXXXXX^XX^X9X9X9^999||9999999999||||||||^^|||||||||N|||\nOBR|1||S16-7232|11529-5^Surgical Pathology Study Report^LN^BX^Biopsy^L|||201604291240|||28621^XXXX^XXXXXX^^^^||||201604291428||^^^^^^||||N||201605021116|||C|||^WYMAN^TANYA^||||99999^XXXX^XXXXXX^XXXXX XXX^^^|||||\n\n\n\n\n\n\n\nPath report.gross description\n\nThe specimen is received in formalin in a container labelled with the patient's demographic details and as \"Left Breast Ultrasound Guided Biopsy\". It consists of 6 cores and fragments of soft white-tan tissue measuring from 0.2 cm to 0.6 cm in length and up to 0.1 cm in diameter.\nSections: A,B - 6/2 EIT\n\n\nCold Ischemic Time:0:00Total Fixation Time:51:20\n\n\nPath report.site of origin\n\nBreast Stereotactic Guided Biopsy, 12:00 Subareolar\n\n\nPath report.final diagnosis\n\nBreast tissue (left breast, 12 o'clock, subareolar), ultrasound guided core biopsy:\n- INVASIVE DUCTAL CARCINOMA\n- Addendum to follow with hormone receptor immunohistochemistry\n\n\nPath Report.addendum spec\n\nINTERPRETATION:\nBlock A from the tumor in the above patient was examined for estrogen and progesterone receptors with the following results:\n           \tResults \t\t% of Positive\tAverage Intensity\n           \t    \t\tCells\nEstrogen Receptor  \tPositive\t\t>95      \tStrong\nProgesterone Receptor\tPositive\t\t2      \tWeak to Moderate\nInternal Control Appropriately Immunoreactive:\tYes\nExternal Control Appropriately Immunoreactive:\tYes\nAppropriate formalin fixation time achieved: \tYes\nAntibody clone 6FII used for estrogen receptor. Antibody clone PR16 used for progesterone receptor.\nA positive result refers to 1% or more of the tumor cell nuclei showing positive staining. Staining intensity is recorded as weak, moderate or strong based on the average staining on the entire tissue section relative to the intensity of positive controls run with the same batch.\n\n\nPath report.relevant Hx\n\nLeft breast mass 0.9cm, probable carcinoma\n\n\n"
}